{
}
Huawei has unveiled its AI WAN network solution at MWC 2025, designed to enhance the growth of 5.5G networks. This innovative solution features a three-layer architecture comprising AI routers, AI new connections, and an AI new brain, which collectively improve network performance and operational efficiency.The AI WAN addresses base station traffic management through predictive operations, enabling carriers to optimize investments and enhance security services, potentially increasing revenue by 35%. Huawei aims to lead in network intelligence innovation, collaborating with partners to advance the Net 5.5G intelligent network era.
At MWC Barcelona 2025, Huawei unveiled its AI WAN Solution, designed to enhance IP networks in the Net5.5G era through a three-layer architecture that integrates AI routers, new connections, and an AI brain. This solution aims to optimize total cost of ownership, improve operational efficiency, and stimulate service growth for carriers. Notable implementations include MTN South Africa's traffic management improvements and partnerships with carriers to enhance user experience and revenue through AI-driven services.
AstraZeneca is enhancing its global operations with a $3.5 billion investment in the U.S. through 2026, creating over 1,000 high-skilled jobs, while navigating challenges in China following leadership changes. Strong demand for cancer and rare-disease treatments has led to improved financial performance, prompting a raised sales outlook. The company’s strategic refresh includes new board appointments to bolster governance and digital capabilities, reflecting confidence in its growth trajectory.
AstraZeneca Plc has appointed Iskra Reic as executive vice-president of its international business, succeeding Leon Wang, who is currently under investigation by Chinese authorities. This change comes shortly after the company confirmed Wang's detention, where he also served as president of Astra's China division.
UBS has maintained a 'Sell' rating on AstraZeneca, setting a target price of 11,300 pence, following insights from a Q&A with the company's China finance chief, Aradhana Sarin. Analyst Matthew Weston noted the positive initiative to engage with the financial market amid an ongoing investigation involving Executive Vice President Leon Wang, although AstraZeneca could not provide a timeline for the investigation's conclusion or potential penalties.
AstraZeneca's shares fell 8.4% on the London Stock Exchange amid concerns over a Chinese investigation into alleged aggressive sales tactics for its oncology drugs, Tagrisso and Imjudo. The company's local president, Leon Wang, is under investigation, signaling increased scrutiny from Beijing. Despite the turmoil, AstraZeneca aims for $80 billion in sales by 2030, up from $45.8 billion in 2023, with plans to launch 20 new drugs by the decade's end.
AstraZeneca shares plummeted 8.4% to a seven-month low following reports that senior executives in China may be involved in a significant insurance fraud case. The investigation, which includes multiple Chinese authorities, centers on allegations of faked prescriptions for the lung cancer drug Tagrisso. The company is cooperating with the investigation while maintaining that its operations in China continue.
AstraZeneca is under investigation in China, with local president Leon Wang implicated, raising concerns about the company's future in the market. The probe focuses on aggressive sales tactics related to its oncology drugs, including the lung cancer treatment Tagrisso and the immunotherapy Imjudo.
AstraZeneca's China president, Leon Wang, is under investigation by Chinese authorities, causing the company's shares to drop by 5.3%. While the company confirmed Wang is cooperating, it remains unclear if he is in custody. AstraZeneca has a strong presence in China, having invested significantly in the market.
AstraZeneca's China President, Leon Wang, is currently under investigation by Chinese authorities. The company has stated that Wang is cooperating with the investigation and will fully assist if requested.
Leon Wang
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Huawei launches AI WAN solution to enhance 5.5G network capabilities
09:32 05.03.2025
Huawei launches AI WAN solution to enhance networks in Net5.5G era
20:05 03.03.2025
AstraZeneca Expands US Operations Amid Challenges in China
AstraZeneca PLC
Sonova R
Arm Holdings plc
USA
CHN
GBR
Birgit Conix
René Haas
Iskra Reic
Leon Wang
Show more
09:55 18.12.2024
AstraZeneca Appoints Iskra Reic as New International Business Head
16:07 04.12.2024
ubs maintains sell rating on astrazeneca with target price of 11300 pence
10:34 07.11.2024
AstraZeneca shares drop amid Chinese investigation into sales practices
19:58 05.11.2024
AstraZeneca shares plunge amid investigation into alleged insurance fraud in China
19:52 05.11.2024
AstraZeneca faces investigation over sales tactics in China oncology drugs
09:10 31.10.2024
AstraZeneca China president under investigation shares drop significantly
15:18 30.10.2024
AstraZeneca China President under investigation by authorities
14:24 30.10.2024
Trending
Subcategory
Industry Trends
Corporate News
Retail and Consumer Goods
Supply Chain Management
Global Trade Developments
Startups & Entrepreneurship
Workplace Trends
Government Economic Policies
Stock Market Updates
Industry Mergers & Acquisitions
CEO Changes
Venture Capital Investments
Fintech Startups
Finance Mergers & Acquisitions
Energy Sector Developments
Emerging Startups
Financial Scams and Security
Cryptocurrency & Blockchain Regulations
Cryptocurrency Trends
Funding Rounds & Investments
Countries:
Companies:
Apple Inc.
Google Inc.
Tesla, Inc.
Alphabet Inc.
Microsoft Corporation
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Samsung SDI Co., Ltd.
SWIGGY LIMITED
Netflix, Inc.
Airbnb, Inc.
Adobe Inc.
GEELY AUTO
Amazon.com, Inc.
TENCENT
CarTrade Tech Limited
Delhivery Limited
Ecom Express Ltd.
CapitaLand Investment Ltd
HMC Capital Ltd
Currencies:
United States Dollar
Chinese Yuan
Euro
Indian Rupee
Japanese Yen
South Korean Won
Indonesian Rupiah
Algerian Dinar
Australian Dollar
Vietnamese Đồng
Egyptian Pound
Saudi Riyal
Swiss Franc
British Pound Sterling
Russian Ruble
People: